BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ribeiro JML, Filizola M. Insights From Molecular Dynamics Simulations of a Number of G-Protein Coupled Receptor Targets for the Treatment of Pain and Opioid Use Disorders. Front Mol Neurosci 2019;12:207. [PMID: 31507375 DOI: 10.3389/fnmol.2019.00207] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Spetea M, Schmidhammer H. Recent Chemical and Pharmacological Developments on 14-Oxygenated-N-methylmorphinan-6-ones. Molecules 2021;26:5677. [PMID: 34577147 DOI: 10.3390/molecules26185677] [Reference Citation Analysis]
2 Neumann A, Engel V, Mahardhika AB, Schoeder CT, Namasivayam V, Kieć-Kononowicz K, Müller CE. Computational Investigations on the Binding Mode of Ligands for the Cannabinoid-Activated G Protein-Coupled Receptor GPR18. Biomolecules 2020;10:E686. [PMID: 32365486 DOI: 10.3390/biom10050686] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
3 Alaofi AL. Exploring structural dynamics of the MERS-CoV receptor DPP4 and mutant DPP4 receptors. J Biomol Struct Dyn 2022;40:752-63. [PMID: 32909925 DOI: 10.1080/07391102.2020.1818626] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Lemel L, Lane JR, Canals M. GRKs as Key Modulators of Opioid Receptor Function. Cells 2020;9:E2400. [PMID: 33147802 DOI: 10.3390/cells9112400] [Reference Citation Analysis]
5 Dumitrascuta M, Bermudez M, Ballet S, Wolber G, Spetea M. Mechanistic Understanding of Peptide Analogues, DALDA, [Dmt1]DALDA, and KGOP01, Binding to the mu Opioid Receptor. Molecules 2020;25:E2087. [PMID: 32365707 DOI: 10.3390/molecules25092087] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
6 Fischer A, Häuptli F, Lill MA, Smieško M. Computational Assessment of Combination Therapy of Androgen Receptor-Targeting Compounds. J Chem Inf Model 2021;61:1001-9. [PMID: 33523669 DOI: 10.1021/acs.jcim.0c01194] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Dumitrascuta M, Bermudez M, Trovato O, De Neve J, Ballet S, Wolber G, Spetea M. Antinociceptive Efficacy of the µ-Opioid/Nociceptin Peptide-Based Hybrid KGNOP1 in Inflammatory Pain without Rewarding Effects in Mice: An Experimental Assessment and Molecular Docking. Molecules 2021;26:3267. [PMID: 34071603 DOI: 10.3390/molecules26113267] [Reference Citation Analysis]
8 Haq MM, Chowdhury MAR, Tayara H, Abdelbaky I, Islam MS, Chong KT, Jeong S. A Report on Multi-Target Anti-Inflammatory Properties of Phytoconstituents from Monochoria hastata (Family: Pontederiaceae). Molecules 2021;26:7397. [PMID: 34885978 DOI: 10.3390/molecules26237397] [Reference Citation Analysis]
9 Puls K, Schmidhammer H, Wolber G, Spetea M. Mechanistic Characterization of the Pharmacological Profile of HS-731, a Peripherally Acting Opioid Analgesic, at the µ-, δ-, κ-Opioid and Nociceptin Receptors. Molecules 2022;27:919. [PMID: 35164182 DOI: 10.3390/molecules27030919] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Sharma KK, Cassell RJ, Meqbil YJ, Su H, Blaine AT, Cummins BR, Mores KL, Johnson DK, van Rijn RM, Altman RA. Modulating β-arrestin 2 recruitment at the δ- and μ-opioid receptors using peptidomimetic ligands. RSC Med Chem 2021;12:1958-67. [PMID: 34825191 DOI: 10.1039/d1md00025j] [Reference Citation Analysis]